Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Phase I: Relapsed or Refractory B-cell Malignancies
View Full LandscapeTarget Indication
Phase I: Relapsed or Refractory B-cell Malignancies
Clinical Trial
NCT03932331Last updated: 2/28/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Hypercholesterolemia
Healthy Japanese Children Age 2 Years Through 6 Years
Generalized Anxiety Disorder
Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer